AbbVie ABBV
NYSE ABBV
$261.90 -4.17 (-1.57%)
At close: Aug 20, 2026 · 4:00 PM EDT

AbbVie (ABBV) EPS (Basic) (2012 - 2026)

AbbVie (ABBV) posted quarterly EPS (Basic) of $0.39 for Q1 2026, down 45.99% year-over-year from $0.73 in Q1 2025, and down 61.62% quarter-over-quarter from $1.03 in Q4 2025.

AbbVie (ABBV) EPS (Basic) (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has reported EPS (Basic) for 15 consecutive years, with $0.39 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) fell 45.99% year-over-year to $0.39; the TTM figure through Mar 2026 stood at $2.06 (down 13.47% YoY), while the FY2025 annual figure was $2.39, down 1.24% from the prior year.
  • EPS (Basic) slipped to $0.39 in Q1 2026 per ABBV's latest filing, from $1.03 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $2.54 in Q1 2022 and bottomed at -$0.05 in Q1 2023.
  • Historically, EPS (Basic) has averaged $0.85 across 5 years, with a median of $0.78 in 2024.
  • Annual changes were most pronounced in 2024 — EPS (Basic) tumbled 102.79% — and 2025, when it surged 7991.3%.
  • AbbVie's EPS (Basic) stood at $1.4 in 2022, then plunged by 66.61% to $0.47 in 2023, then sank by 102.79% to -$0.01 in 2024, then soared by 7991.3% to $1.03 in 2025, then tumbled by 61.62% to $0.39 in 2026.
  • Business Quant data shows ABBV's EPS (Basic) at $0.39 in Q1 2026, $1.03 in Q4 2025, and $0.11 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 2.30
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 2.04
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -0.54
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 1.71
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 1.62
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 4.40
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -8.44
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -0.04
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 0.29
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 0.33

Historic Data

Download Data
DateValue
Jun 30, 2026 2.04
Mar 31, 2026 0.39
Dec 31, 2025 1.03
Sep 30, 2025 0.11
Jun 30, 2025 0.53
Mar 31, 2025 0.73
Dec 31, 2024 -0.01
Sep 30, 2024 0.88
Jun 30, 2024 0.78
Mar 31, 2024 0.78
Dec 31, 2023 0.47
Sep 30, 2023 1.01
Jun 30, 2023 1.15
Mar 31, 2023 -0.05
Dec 31, 2022 1.40
Sep 30, 2022 2.23
Jun 30, 2022 0.52
Mar 31, 2022 2.54
Dec 31, 2021 2.29
Sep 30, 2021 1.80